Jing Xu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Acute Respiratory Distress Syndrome

Multiple Myeloma

Top Venues

Therapeutic advances in hematology

Molecular cancer research : MCR

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Xu, Yixin Yan, Siwen Zong, Wencan Ye, Jifu Zheng, Chao Min, Qingming Wang, Zhenjiang Li
Rapid and sustained response to luspatercept and eltrombopag combined treatment in one case of clonal cytopenias of undetermined significance with prior failure to cyclosporin and androgen therapy: a case report. Therapeutic advances in hematology 15 (2024)
Jing Xu, Yixin Yan, Siwen Zong, Wencan Ye, Jifu Zheng, Chao Min, Qingming Wang, Zhenjiang Li
Rapid and sustained response to luspatercept and eltrombopag combined treatment in one case of clonal cytopenias of undetermined significance with prior failure to cyclosporin and androgen therapy: a case report. Therapeutic advances in hematology 15 (2024)
Qing-Ming Wang, Guang-Yu Lian, Su-Mei Sheng, Jing Xu, Long-Long Ye, Chao Min, Shu-Fang Guo
Exosomal lncRNA NEAT1 inhibits NK cell activity to promote multiple myeloma cell immune escape via an EZH2/PBX1 axis. Molecular cancer research : MCR (2023)
Jing Xu, Yong Kang, Yan Zhong, Wencan Ye, Tianle Sheng, Qingming Wang, Jifu Zheng, Qiuyue Yang, Ping Yi, Zhenjiang Li
Alteration of gut microbiome and correlated amino acid metabolism are associated with acute myelocytic leukemia carcinogenesis. Cancer medicine (2023)